These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1758890

  • 1. Polymorphism of carbamazepine: solid-state studies on carbamazepine dihydrate.
    Dugué J, Céolin R, Rouland JC, Lepage F.
    Pharm Acta Helv; 1991; 66(11):307-10. PubMed ID: 1758890
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Influence of environmental conditions on the kinetics and mechanism of dehydration of carbamazepine dihydrate.
    Han J, Suryanarayanan R.
    Pharm Dev Technol; 1998 Nov; 3(4):587-96. PubMed ID: 9834963
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In situ dehydration of carbamazepine dihydrate: a novel technique to prepare amorphous anhydrous carbamazepine.
    Li Y, Han J, Zhang GG, Grant DJ, Suryanarayanan R.
    Pharm Dev Technol; 2000 Nov; 5(2):257-66. PubMed ID: 10810755
    [Abstract] [Full Text] [Related]

  • 6. Changes in the solid state of anhydrous and hydrated forms of sodium naproxen under different grinding and environmental conditions: Evidence of the formation of new hydrated forms.
    Censi R, Rascioni R, Di Martino P.
    Eur J Pharm Biopharm; 2015 May; 92():192-203. PubMed ID: 25796350
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice disorder.
    Murphy D, Rodríguez-Cintrón F, Langevin B, Kelly RC, Rodríguez-Hornedo N.
    Int J Pharm; 2002 Oct 10; 246(1-2):121-34. PubMed ID: 12270615
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. De- and rehydration behavior of alpha,alpha-trehalose dihydrate under humidity-controlled atmospheres.
    Furuki T, Kishi A, Sakurai M.
    Carbohydr Res; 2005 Feb 28; 340(3):429-38. PubMed ID: 15680598
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Solid state dehydration processes: mechanism of water loss from crystalline inosine dihydrate.
    Gillon AL, Davey RJ, Storey R, Feeder N, Nichols G, Dent G, Apperley DC.
    J Phys Chem B; 2005 Mar 24; 109(11):5341-7. PubMed ID: 16863200
    [Abstract] [Full Text] [Related]

  • 15. One-solvent polymorph screen of carbamazepine.
    Getsoian A, Lodaya RM, Blackburn AC.
    Int J Pharm; 2008 Feb 04; 348(1-2):3-9. PubMed ID: 17945448
    [Abstract] [Full Text] [Related]

  • 16. In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour.
    Qiao N, Wang K, Schlindwein W, Davies A, Li M.
    Eur J Pharm Biopharm; 2013 Apr 04; 83(3):415-26. PubMed ID: 23159709
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of dehydration temperature on water vapor adsorption and dissolution behavior of carbamazepine.
    Ono M, Tozuka Y, Oguchi T, Yamamura S, Yamamoto K.
    Int J Pharm; 2002 Jun 04; 239(1-2):1-12. PubMed ID: 12052686
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Investigating Cocrystallization of Carbamazepine with Structurally Compatible Coformers: New Cocrystal and Eutectic Phases with Enhanced Dissolution.
    Sathisaran I, Dalvi SV.
    AAPS PharmSciTech; 2021 Jan 06; 22(1):29. PubMed ID: 33404968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.